Last reviewed · How we verify

NCT01489293

Inhibitory Receptors in Eosinophils of Atopic Subjects

Completed Last updated 22 March 2018
What this trial tests

trial in Atopy in 40 participants. Completed in 31 December 2013.

Timeline
1 May 2012
Primary endpoint
31 December 2013
31 December 2013

Quick facts

Lead sponsorMeir Medical Center
StatusCompleted
Study typeOBSERVATIONAL
Enrollment40
Start date1 May 2012
Primary completion31 December 2013
Estimated completion31 December 2013
Sites1 location across Israel

Conditions studied

Sponsor

Meir Medical Center

Who can join

Adults 20 to 60, any sex, with Atopy or Atopic Dermatitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to analyze the expression and activity of inhibitory molecules on eosinophils obtained from allergic subjects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Atopy

Currently open trials in the same condition.

Other Meir Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01489293.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing